TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Similarly, mutations in the transmembrane 6 superfamily member 2 (TM6SF2) gene can lead to reduced secretion of very low-density lipoprotein (VLDL), resulting in hepatic fat accumulation and an increased risk of non-alcoholic fatty liver disease (NAFLD) (107).